Other clinical studies evaluating similar combinations in RAS-mutant colorectal cancer (NCT03981614), KRAS-mutant NSCLC (NCT03170206), and in children and young adults with brain tumors (NCT03434262) are ongoing. The gene discussed is KRAS; the disease is colorectal cancer.